- Home
- OCGN vs NCA Comparison
OCGN vs NCA Comparison
Compare OCGN & NCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- NCA
- Stock Information
- Founded
- OCGN 2013
- NCA 1987
- Country
- OCGN United States
- NCA United States
- Employees
- OCGN N/A
- NCA N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- NCA Investment Managers
- Sector
- OCGN Health Care
- NCA Finance
- Exchange
- OCGN Nasdaq
- NCA Nasdaq
- Market Cap
- OCGN 278.3M
- NCA 279.1M
- IPO Year
- OCGN N/A
- NCA N/A
- Fundamental
- Price
- OCGN $1.03
- NCA $8.58
- Analyst Decision
- OCGN Strong Buy
- NCA
- Analyst Count
- OCGN 3
- NCA 0
- Target Price
- OCGN $6.00
- NCA N/A
- AVG Volume (30 Days)
- OCGN 8.5M
- NCA 59.6K
- Earning Date
- OCGN 08-07-2025
- NCA 01-01-0001
- Dividend Yield
- OCGN N/A
- NCA 3.92%
- EPS Growth
- OCGN N/A
- NCA N/A
- EPS
- OCGN N/A
- NCA N/A
- Revenue
- OCGN $4,522,000.00
- NCA N/A
- Revenue This Year
- OCGN N/A
- NCA N/A
- Revenue Next Year
- OCGN N/A
- NCA N/A
- P/E Ratio
- OCGN N/A
- NCA N/A
- Revenue Growth
- OCGN N/A
- NCA N/A
- 52 Week Low
- OCGN $0.52
- NCA $7.77
- 52 Week High
- OCGN $1.98
- NCA $9.12
- Technical
- Relative Strength Index (RSI)
- OCGN 55.00
- NCA 52.12
- Support Level
- OCGN $0.95
- NCA $8.41
- Resistance Level
- OCGN $1.15
- NCA $8.48
- Average True Range (ATR)
- OCGN 0.11
- NCA 0.08
- MACD
- OCGN -0.02
- NCA 0.00
- Stochastic Oscillator
- OCGN 22.62
- NCA 45.00
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About NCA Nuveen California Municipal Value Fund
Nuveen California Municipal Value Fund Inc is a diversified closed-end management investment company. Its primary objective is to provide current income exempt from regular federal and California income taxes. The fund's secondary objective is to enhance portfolio value relative to the California municipal bond market by investing in tax-exempt California municipal securities that the Fund's investment adviser and/or the Fund's sub-adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.